Who is buying NovaBridge Biosciences (NBP)?

As of 20 November 2026: Insiders bought $647k on the open market (2 buys of $50k or more); the latest was Hagler Mark Arnold (Chief Commercial Officer), $70k, filed 2026-11-19. ETFs reported 0 buys or adds and 2 trims or sales since their previous reports (net +$0k).

Insider buys, 12 months$647k

Insider buys

FiledWhoRoleAmountPrice
2026-11-19Hagler Mark ArnoldChief Commercial Officer$70k$0.38
2026-04-28Hagler Mark Arnoldinsider$577k$2.51

ETF changes

ETFChangeValueReport
State Street(R) Spdr(R) S&p(R) Emerging Markets Small Cap ETFTRIM−$0k2026-06-30
State Street(R) Spdr(R) S&p(R) China ETFTRIM−$0k2026-06-30

NovaBridge Biosciences: questions and answers

Are insiders buying NBP?

Yes: 2 open-market buys of $50k or more in the last 12 months, $647k in total. The latest was filed 2026-11-19.

Open the live smart money map